Internal Medicine, Hematology & Oncology · West Columbia, SC
NPI
1841223047
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
222 E Medical Ln Ste 400
West Columbia, SC, 29169
Phone (803) 794-7511
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.2M
237,903 services
Medicare patients, 2024
1,195
Average age 74
Drug cost, 2024
$11.0M
2,429 prescriptions
Company payments, 2025
$734
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asheesh Lal was code J1439 (injection, ferric carboxymaltose, 1 mg), 36,750 times for 46 patients. In total Asheesh Lal billed 237,903 services in 210 codes, and Medicare paid $4.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 36,750 | 46 | $0.86 | $32K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,200 | 58 | $43.15 | $915K |
| J0897 Injection, denosumab, 1 mg | Office | 14,640 | 85 | $20.62 | $302K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 12,540 | 17 | $0.22 | $2,759 |
| J0185 Injection, aprepitant, 1 mg | Office | 12,480 | 63 | $1.37 | $17K |
| J9299 Injection, nivolumab, 1 mg | Office | 11,960 | 22 | $24.72 | $296K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 11,772 | 22 | $0.06 | $669 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 11,105 | 107 | $0.10 | $1,130 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 7,920 | 18 | $36.99 | $293K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 4,800 | 19 | $0.11 | $516 |
| J9267 Injection, paclitaxel, 1 mg | Office | 3,833 | 15 | $0.08 | $293 |
| J9171 Injection, docetaxel, 1 mg | Office | 2,014 | 13 | $0.59 | $1,189 |
| 85025 Blood Count | Office | 1,867 | 642 | $7.55 | $14K |
| J9312 Injection, rituximab, 10 mg | Office | 1,800 | 19 | $60.99 | $110K |
| 36415 Venipuncture Blood Collection | Office | 1,768 | 602 | $8.39 | $15K |
By year: 2022 $3.7M for 227,292 services; 2023 $4.4M for 260,147 services; 2024 $4.2M for 237,903 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,867 | 642 | $7.55 | $14K |
| 36415 Venipuncture Blood Collection | 1,768 | 602 | $8.39 | $15K |
| 80048 Clinical Chemistry | 1,352 | 532 | $8.22 | $11K |
| 80076 Clinical Chemistry | 1,251 | 500 | $7.94 | $9,933 |
| 82728 Clinical Chemistry | 342 | 211 | $13.28 | $4,541 |
| 83540 Clinical Chemistry | 312 | 204 | $6.30 | $1,965 |
| 83550 Clinical Chemistry | 312 | 204 | $8.51 | $2,656 |
| 80053 Clinical Chemistry | 276 | 194 | $10.17 | $2,807 |
| 83735 Clinical Chemistry | 171 | 77 | $6.57 | $1,123 |
| 84153 Clinical Chemistry | 168 | 71 | $17.31 | $2,908 |
Medicare prescription drug claims, 2024
In 2024, the drug Asheesh Lal prescribed most often to Medicare patients was Prednisone, with 133 prescriptions and refills. In total Asheesh Lal wrote 2,429 Medicare prescriptions that cost $11.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 133 | 145 | 28 | $632 |
| Xtandi Enzalutamide | 122 | 122 | 12 | $1.7M |
| Acyclovir Generic | 120 | 206 | 27 | $2,275 |
| Anastrozole Generic | 106 | 285 | 33 | $2,947 |
| Revlimid Lenalidomide | 99 | 99 | 12 | $1.6M |
| Abiraterone Acetate Generic | 90 | 90 | 12 | $456K |
| Eliquis Apixaban | 73 | 110 | 25 | $61K |
| Ondansetron Odt Ondansetron | 67 | 67 | 41 | $1,003 |
| Lenalidomide Generic | 57 | 57 | Under 11 | $808K |
| Hydroxyurea Generic | 54 | 103 | 19 | $1,315 |
| Prochlorperazine Maleate Generic | 51 | 51 | 36 | $621 |
| Dexamethasone Generic | 51 | 58 | 26 | $1,021 |
| Gabapentin Generic | 48 | 62 | 16 | $370 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 48 | 48 | 23 | $1,163 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 40 | 80 | 12 | $448 |
Brand drugs: 770 claims; generic drugs: 1,659 claims; opioid claims: 139.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asheesh Lal $734 ($734 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novartis Pharmaceuticals Corporation with $202.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $202 |
| Abbvie Inc. ABBV | 4 | $93.98 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $62.31 |
| GlaxoSmithKline, LLC. GSK | 3 | $60.92 |
| Celgene Corporation BMY | 3 | $60.67 |
| Daiichi Sankyo Inc. 4568.T | 2 | $39.56 |
| Gilead Sciences, Inc. GILD | 2 | $35.16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27.94 |
| Taiho Oncology, Inc. 4578.T | 1 | $24.33 |
| Kite Pharma, Inc. GILD | 1 | $22.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.